These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6340223)

  • 21. Diabetics treated with continuous subcutaneous insulin infusion pumps.
    Foley-Nolan D; Foley-Nolan A; Temperley D; Devlin J
    Ir Med J; 1989 Dec; 82(4):159-60. PubMed ID: 2516015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dual-wave bolus feature in continuous subcutaneous insulin infusion pumps controls prolonged post-prandial hyperglycaemia better than standard bolus in Type 1 diabetes.
    Lee SW; Cao M; Sajid S; Hayes M; Choi L; Rother C; de León R
    Diabetes Nutr Metab; 2004 Aug; 17(4):211-6. PubMed ID: 15575341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [From external to implantable insulin pump, can we close the loop?].
    Renard E; Costalat G; Bringer J
    Diabetes Metab; 2002 Sep; 28(4 Pt 2):2S19-2S25. PubMed ID: 12442060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin pumps--still a research tool?
    Lauritzen T; Pramming S
    Ann Clin Res; 1984; 16(2):98-106. PubMed ID: 6380393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Intensified insulin therapy and insulin micro-pumps during pregnancy].
    Galuppi V
    Minerva Endocrinol; 1994 Jun; 19(2):79-83. PubMed ID: 7968932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thoracic epidural anesthesia and blood glucose levels in diabetic patients undergoing cardiopulmonary bypass under insulin infusion according to the Portland protocol.
    Sener M; Caliskan E; Bozdogan N; Kocum A; Oner SO; Atalay H; Kayhan Z
    Exp Clin Endocrinol Diabetes; 2010 Mar; 118(3):190-4. PubMed ID: 19834875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous subcutaneous insulin therapy during early pregnancy.
    Kitzmiller JL; Younger MD; Hare JW; Phillippe M; Vignati L; Fargnoli B; Grause A
    Obstet Gynecol; 1985 Nov; 66(5):606-11. PubMed ID: 4058818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term continuous subcutaneous insulin infusion in diabetics at home.
    Pickup JC; White MC; Keen H; Parsons JA; Alberti KG
    Lancet; 1979 Oct; 2(8148):870-3. PubMed ID: 90966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy.
    Renard E
    Curr Opin Pharmacol; 2002 Dec; 2(6):708-16. PubMed ID: 12482735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia.
    Pickup JC; Keen H; Parsons JA; Alberti KG
    Br Med J; 1978 Jan; 1(6107):204-7. PubMed ID: 340000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term, ambulatory, subcutaneous insulin infusion versus multiple daily injections in brittle diabetic patients.
    Barbosa J; Menth L; Eaton J; Sutherland D; Freier EF; Najarian J
    Diabetes Care; 1981; 4(2):269-74. PubMed ID: 7011745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term ambulatory peritoneal insulin infusion of brittle diabetes with portable pumps: comparison with intravenous and subcutaneous routes.
    Selam JL; Slingeneyer A; Hedon B; Mares P; Beraud JJ; Mirouze J
    Diabetes Care; 1983; 6(2):105-11. PubMed ID: 6406198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Achieving effective glycaemic control using an insulin micro-pump.
    Kelly P
    Br J Community Nurs; 2017 Feb; 22(2):66-76. PubMed ID: 28161977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of an implantable insulin pump in the treatment of type II diabetes.
    Rupp WM; Barbosa JJ; Blackshear PJ; McCarthy HB; Rohde TD; Goldenberg FJ; Rublein TG; Dorman FD; Buchwald H
    N Engl J Med; 1982 Jul; 307(5):265-70. PubMed ID: 7045666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Short-term subcutaneous infusion of insulin using a portable insulin pump in the treatment of diabetes mellitus].
    Krzymień J; Szymerska E; Bak M; Regulski M; Tracz M
    Pol Arch Med Wewn; 1989 Apr; 81(4):214-22. PubMed ID: 2626347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of continuous subcutaneous insulin infusion: metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion.
    Pickup JC; Viberti GC; Bilous RW; Keen H; Alberti KG; Home PD; Binder C
    Diabetologia; 1982 Mar; 22(3):175-9. PubMed ID: 7042428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pumps for insulin infusion in the ambulatory treatment of diabetes mellitus].
    Mirouze J
    Presse Med; 1987 Oct; 16(32):1585-90. PubMed ID: 2958834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucose control in mobile type 1 (insulin-dependent) diabetic patients by means of a semi-automatic feedback controlled insulin infusion system.
    Piwernetz K; Renner R; Hepp KD
    Diabetologia; 1982 Sep; 23(3):229-34. PubMed ID: 7128971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control of insulin-dependent diabetes with portable miniaturized infusion systems.
    Hepp KD; Renner R; Piwernetz K; Mehnert H
    Diabetes Care; 1980; 3(2):309-13. PubMed ID: 6993145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient reactions to long-term outpatient treatment with continuous subcutaneous insulin infusion.
    Pickup JC; Keen H; Viberti GC; Bilous RW
    Br Med J (Clin Res Ed); 1981 Mar; 282(6266):766-8. PubMed ID: 6783163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.